Citations

Clear

4531 citation(s) found for "Trêpa, Maria".

Primary Amenorrhea: Diagnostic Approach, Imaging Spectrum, and Common Pitfalls
Trila, Maria Florencia , Mac Allister, Kevin K , Aineseder, Martina , Gomez, Erin N , Ainsworth, Alessandra J. , Jha, Priyanka , Kreindel, Tamara G , Poder, Liina , Causa Andrieu, Pamela

Mayo Clinic

RadioGraphics | November 12, 2026 | Volume: 46 | Issue: 12 | Pages: No page available

10.1148/rg.250140 | PMID 43019229 Get It

Primary amenorrhea reflects disruption along the hypothalamic-pituitary-ovarian-uterine axis; may arise from anatomic, genetic, or functional abnormalities; and may be diagnosed on the basis of US and MRI findings.
Patient choice and uptake of Home-based rehabilitation with Health coaching versus Center-based pulmonary rehabilitation after a COPD-related hospitalization
Beenken, Madison, Hoult, Johanna, Midthun, William, Benzo, Maria

Mayo Clinic

Annals of the American Thoracic Society | November 11, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1093/annalsats/aaoag349 | PMID 43009181 Get It

Abstract Rationale Adherence to center-based pulmonary rehabilitation after a COPD-related hospitalization—which improves all outcomes, including survival—is only 3%. Home-based programs have been proposed as a more feasible option, but they are not systematically offered, and patient preference is unknown. Objectives and Methods This pragmatic randomized trial involving patients with COPD recently hospitalized for a COPD exacerbation, originally aimed to investigate the comparative effect two arms: The choice of a facilitated referral to a center-based outpatient pulmonary rehabilitation program or a home-based program versus a home-based program on adherence to post-hospitalization rehabilitation and disease-specific QoL measured by the Chronic Respiratory Questionnaire. The trial aimed to investigate the patient’s preference of home vs center-based rehabilitation in individuals randomized to the choice arm. Daily steps were measured by Actigraph ®. The asynchronous home-based program included weekly health coaching and daily monitoring of daily steps, symptoms, and a 20-minute daily flexibility-balance exercise routine. Results Of 1,906 patients approached, 294 (15%) were randomized and agreed to the rehabilitation options offered by the study arms (uptake); of those, 56% completed the 12-week intervention (adherence). Of the 145 randomized to the choice arm, only one patient chose center-based PR; therefore, both groups received the same intervention, and results are presented as a one-group (before–after) analysis. Compared with baseline, the home intervention significantly improved (p < 0.01) physical and emotional QoL (Chronic Respiratory Questionnaire) and increased daily steps beyond the minimal clinically important difference. Trajectory models adjusted for age, FEV1%, and mMRC (breathlessness) confirmed sustained improvements in QoL at 6 and 12 months from baseline. Conclusions When offered a choice of rehabilitation setting after a COPD-related hospital admission for an exacerbation, home-based rehabilitation is patients’ preferred option. Sustained quality-of-life improvements in 1 year may represent an opportunity to regain well-being and/or deliver primary palliative care. Our results may have important implications for clinical practice.
Validation of an LC-Q-TOF “HiRes Mass-fix” assay for improved sensitivity and specificity of M-protein detection
Pearce, Ryan W , Kohlhagen, Mindy C, Willrich, Maria A V

Mayo Clinic

Clinical Chemistry and Laboratory Medicine (CCLM) | November 10, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1515/cclm-2026-1525 | PMID 43007724 Get It

Abstract Objectives To validate a blood-based liquid chromatography quadrupole time-of-flight mass spectrometry (MS) method “HiRes Mass-Fix” as a fit-for-purpose, patient-specific method for detecting low level M-proteins in patients who have reached negativity by MALDI-TOF MS “Mass-Fix”. Methods Analytical validation included precision, accuracy, analytical measurement interval, limit of detection, specificity, ion suppression, carryover, and extracted-sample stability. Clinical performance was assessed by comparing 174 patients with bone marrow (BM) measurable residual disease (MRD) by next-generation flow cytometry (NGF) to both Mass-Fix and HiRes Mass-Fix. Results HiRes Mass-Fix demonstrated acceptable precision, accuracy, linearity, specificity, and stability for its intended use, with an average limit of detection of 3.8 mg/L. HiRes Mass-Fix detected M-proteins in 41 of 58 Mass-Fix negative samples. This raised blood MRD positivity from 62 to 89 % against a BM NGF positivity rate of 51 %. Blood-BM agreement fell from 71 % (kappa 0.43) by Mass-Fix to 58 % (kappa 0.15) by HiRes Mass-Fix, driven by blood-positive/BM-negative discordance. IgG was overrepresented among discordant cases (68 vs. 45 %, p=0.003). Conclusions HiRes Mass-Fix was successfully validated and demonstrated to increase M-protein detection in samples negative by Mass-Fix. IgG recycling may explain the blood-positive/BM-negative discordance, and serial measurements will be needed to distinguish residual M-protein from ongoing production. Blood-based M-protein measurement is a less invasive, lower-cost alternative to bone marrow biopsy for ongoing patient monitoring.
Genetic Heterogeneity of Asthma Across Sex, Age at Onset, and Disease Severity
Kyriakidou, Maria , Silveyra, Patricia , Kling, Juliana M , Gaston, Benjamin , Fernandez, Gerry, Keswani, Shiwani, Nixon, Lacey, Zein, Joe G

Mayo Clinic

Clinical & Experimental Allergy | October 26, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1111/cea.70466 | PMID 42933388 Get It

Summary Asthma genetic architecture varies according to age at onset and biological sex. Medication‐defined severity showed limited common variant genetic heterogeneity compared with age at onset and sex.
Safety and Feasibility of Reduced-Frequency Dosing of Axatilimab in Patients Treated in the AGAVE-201 Study
Farhadfar, Nosha , Soto, Maria Sola, Chhabra, Saurabh , Bhatt, Valkal, Andersen, Emily Helen, Xue, Zhenyi , DeFilipp, Zachariah

Mayo Clinic

Blood Advances | October 23, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1182/bloodadvances.2026021323 | PMID 42913434 Get It

Biliary and Pancreatic Safety of Incretin-Based Therapies in Obesity and Type 2 Diabetes: A Propensity-Matched Real-World Comparison of Tirzepatide, Semaglutide, and DPP-4 Inhibitors
Ghusn, Wissam , Abi-Aad, Sasha-Jane , Hurtado, Maria Daniela

Mayo Clinic

Journal of Clinical Medicine | October 16, 2026 | Volume: 15 | Issue: 20 | Pages: 8027

10.3390/jcm15208027 | PMID 42941539 Get It

To compare the 1-year risk of biliary/pancreatic adverse events among patients with obesity and type 2 diabetes treated with glucagon-like peptide-1 receptor agonists (GLP-1RAs) versus dipeptidyl peptidase-4 inhibitors (DPP-4i), and to directly compare tirzepatide with semaglutide. Methods: We conducted a retrospective propensity score-matched cohort study using the TriNetX Global Collaborative Network. Adults with obesity and type 2 diabetes without prior biliary or pancreatic disease were included. Two prespecified comparisons were performed: GLP-1RA (semaglutide or tirzepatide) versus DPP-4i, and tirzepatide versus semaglutide. The primary outcome was incident cholelithiasis at 1 year. Secondary outcomes included cholecystitis, cholangitis, acute pancreatitis, and cholecystectomy. Hazard ratios (HRs) were estimated using Cox proportional hazards models. Results: After matching, 281,283 patients were included in each GLP-1RA and DPP-4i cohort, and 242,876 patients in each tirzepatide and semaglutide cohort. Compared with DPP-4i, GLP-1RA therapy was associated with lower risks of cholelithiasis (1.02% vs. 1.16%; HR 0.92, 95%CI 0.87–0.96), cholecystitis (HR 0.88, 95%CI 0.79–0.98), cholangitis (HR 0.46, 95%CI 0.36–0.58), acute pancreatitis (HR 0.68, 95%CI 0.61–0.76), and cholecystectomy (HR 0.51, 95%CI 0.38–0.69). In the head-to-head comparison, semaglutide was associated with higher risks of cholelithiasis (HR 1.11, 95%CI 1.05–1.18) and cholecystitis (HR 1.22, 95%CI 1.10–1.37) compared with tirzepatide, while risks of pancreatitis, cholangitis, and cholecystectomy did not differ significantly. Conclusions: In this large real-world study, GLP-1RA therapy was associated with lower risks of biliary and pancreatic events compared with DPP-4i. Tirzepatide demonstrated a modestly more favorable biliary safety profile than semaglutide, supporting the overall hepatobiliary safety of contemporary GLP-1-based therapies.
Evaluation of Otolaryngology Residency and Faculty Demographics Following the Single Accreditation System
Echevarria‐Cruz, Evelyn , Hart, Sky , Fioletova, Maria, Smith, Arkhum, Avirineni, Siri, Rutt, Amy L.

Mayo Clinic

Otolaryngology–Head and Neck Surgery | October 13, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1002/ohn.70486 | PMID 42867231 Get It

Abstract Objective Otolaryngology–Head and Neck Surgery (OHNS) residency remains highly competitive, with persistent disparities in applicant representation. This study presents a cross‐sectional analysis of OHNS residency and faculty demographics using 2025 program rosters, evaluating degree type (MD vs DO), geographic distribution, and leadership influence. Study Design A cross‐sectional review. Setting All US ACGME‐accredited OHNS residency programs, with data collected in 2024 to 2025. Methods Demographic data were collected on OHNS faculty and residents, including post‐graduate year (PGY) 1 through PGY5 trainees at the time of data collection, corresponding to entry years from 2020 to 2024 across all US ACGME‐accredited residency programs. Data was extracted from official program websites, FREIDA, ACGME, NRMP, and social media. Programs with incomplete data, those using the military match, and non‐accredited sites were excluded. Descriptive statistics, χ 2 tests, and correlation analyses were performed ( p < .05). Results Of 131 programs, 125 were analyzed at the program level and 121 at the faculty level. DO residents were concentrated in Michigan (59%), Ohio (50%), and Oklahoma (50%). DO representation correlated with DO faculty ( r = .82, p < .0001), DO program director ( r = .95, p < .0001), and former AOA program designation ( r = .92, p < .0001). A negative correlation existed between program size and DO resident ( r = –.4, p < .0001). Conclusion Despite growing diversity following the single accreditation system, disparities persist in OHNS. DO residents remain underrepresented and geographically concentrated, with representation strongly associated with osteopathic faculty presence, program leadership, and prior AOA affiliation.
Atrial Fibrillation in Patients With Pectus Excavatum: Clinical Characteristics, Management, and Outcomes
Habib, Eiad , Mohammed, Arshad , Gotway, Michael B , Wallace, Alyssa, Abdul Nabi, Hussein , Rodriguez-Riascos, Juan F , Youssef, Amal , Koepke, Laura, Odeh, Nour , Villa Etchegoyen, Cecilia , Abdelnabi, Mahmoud , Senjab, Abdulrahman , Farina, Juan María, Sorajja, Dan , El Masry, Hicham , Jaroszewski, Dawn, Srivathsan, Komandoor

Mayo Clinic

Pacing and Clinical Electrophysiology | October 6, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1111/pace.70462 | PMID 42834350 Get It

ABSTRACT Background Pectus excavatum (PE), the most common congenital chest wall deformity, has known associations with connective tissue disorders and may lead to cardiopulmonary impairment; however, its relationship with atrial fibrillation (AF) remains underexplored. Objectives This study aimed to describe the frequency, clinical characteristics, and management of AF within an institutional cohort of patients with PE, and to determine whether the outcomes observed in clinically distinct subgroups persisted after adjustment for baseline risk. Methods This was a retrospective cohort study design. Patients with both PE and documented AF between January 1, 1990, and November 10, 2024, were included. Clinical, echocardiographic, and therapeutic data were collected. Bleeding and thromboembolic outcomes were evaluated using multivariable logistic regression adjusted for age, sex, CHA 2 DS 2 ‐VASc score, and anticoagulant class, and the surgically treated subgroup was additionally compared using propensity score matching. Results Among 11,578 patients with PE, 1309 (11.3%) had AF. Of those who had AF, mean age was 66.9 years; 54% were female, and 83% had paroxysmal AF. The mean CHA 2 DS 2 ‐VASc and HAS‐BLED scores were 2.8 and 1.9, respectively. Thromboembolic events occurred in 196 (15%) patients, most commonly stroke (11%), followed by pulmonary embolism (4%) and deep venous thrombosis (4%). Bleeding events occurred in 313 patients (24%), most commonly hematuria (12%), gastrointestinal bleed (11%), epistaxis (5%), and intracranial hemorrhage (1%). Seventy‐two patients (6%) underwent the Nuss procedure and were younger (45.3 vs. 68.2 years, p < 0.001), predominantly male (65%), and had lower risk scores compared to the non‐Nuss cohort. Patients who underwent the Nuss procedure had significantly fewer bleeding events (5.6% vs. 25%, p < 0.001) with similar thromboembolic rates. The pectus severity index, available in the 370 patients who underwent dedicated radiologic review, was not associated with bleeding (adjusted OR 0.89, 95% CI 0.75–1.05). The difference in bleeding by surgical status persisted after multivariable adjustment (adjusted OR 0.28, 95% CI 0.10–0.79) and after propensity score matching (5.6% vs. 16.7%, p = 0.030). Conclusions AF was identified in approximately one in nine patients within this single‐institution cohort of adults with PE, with paroxysmal AF representing the predominant subtype. Patients who had undergone surgical repair demonstrated a lower incidence of bleeding events than anticipated based on their baseline risk profile; however, given the limited number of events observed, this finding should be interpreted with caution and requires validation in larger studies. In the absence of a non–PE comparator group, these data are insufficient to determine whether PE independently confers an elevated risk of AF, and prospective, controlled investigations are necessary to elucidate this relationship.
What Happens after an Incidental Thyroid Nodule? Patterns of Thyroid Ultrasound Use and Downstream Evaluation
Larios, Felipe , Vilatuna Andrango, Luis, Borras-Osorio, Mariana , Branda, Megan , Toro-Tobon, David , Cabezas, Esteban , Mateo Chavez, Maria, Claros, Ana Gabriela , Lizarazo Jimenez, Maria, Alzamora, Ivan Mateo , Gomez-Alvarez, Esteban , Al Zahidy, Misk , Fan, Jungwei W, Ponce, Oscar Josue

Mayo Clinic

Thyroid® | September 30, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1177/10507256261493769 | PMID 42813606 Get It

Background: Incidental thyroid nodules (ITNs) detected on nonthyroid imaging contribute to thyroid cancer overdiagnosis, largely through downstream evaluation initiated by thyroid ultrasound (TUS). However, TUS follow-up rates for ITNs and their drivers in routine practice remain unclear. We quantified TUS utilization after ITN detection and identified patient, imaging, nodule, and reporting factors associated with this first step in the diagnostic cascade. Methods: We conducted a retrospective cohort study of adults without prior thyroid disease who underwent imaging that incidentally captured the thyroid at Mayo Clinic sites (2017–2023). A validated natural language processing pipeline identified ITNs and extracted nodule characteristics from radiology reports across multiple imaging modalities. The main outcome was the rate of TUS within 180 days after ITN detection. Clinical outcomes, including thyroid biopsy, thyroidectomy, and thyroid cancer diagnosis, were compared between patients who underwent TUS and those who did not. Factors associated with TUS utilization were assessed using multivariable logistic regression with penalized variable selection. Results: Among 115,683 patients who underwent thyroid-capturing imaging, 8426 (7.3%) had an ITN. These patients were predominantly female (64.6%) and White (89.7%), with a mean age of 61.7 years (standard deviation 15.2). Most nodules were detected on computed tomography (80.8%), most commonly from chest imaging (52.3%). Overall, 1677 patients with ITNs (19.9%) underwent TUS. In multivariable analysis, TUS use was independently associated with higher body mass index (odds ratio [OR], 1.20 per 10-unit increase; confidence interval [CI] [1.08–1.33]), nodule size ≥1.5 cm (OR, 1.79; CI [1.52–2.10]), and a radiologist recommendation (OR, 2.51; CI [2.12–2.98]), whereas older age was associated with lower odds of TUS (OR, 0.89 per 10-year increase; CI [0.84–0.93]). Patients undergoing TUS had higher rates of thyroid biopsy, partial thyroidectomy, and total thyroidectomy compared with those without it. All detected thyroid cancers (103 cases) occurred in the TUS group, representing 6.1% of that cohort. Conclusions: One in five patients with ITNs underwent TUS, representing a critical gateway to downstream diagnostic procedures and thyroid cancer detection. Factors associated with TUS utilization highlight opportunities to better define appropriateness of ultrasound after incidental nodule detection and to reduce unnecessary testing and treatment.